Condition
Percutaneous Coronary Revascularization
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
2Total
P 3 (1)
P 4 (1)
Trial Status
Completed1
Unknown1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03788369TerminatedPrimary
Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization
NCT04837001Phase 3Completed
Evaluation in STEMI Patients Using FDY-5301
NCT05803759Phase 4Unknown
The Effects of Allicor on Patients After Coronary Arteria Revascularization Treatment
Showing all 3 trials